✦ LIBER ✦

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

✍ Scribed by van der Heijden, Antoine G.; Moonen, Paula M.J.; Cornel, Erik B.; Vergunst, Henk; de Reijke, Theo M.; van Boven, Erika; Barten, Evert J.; Puri, Rajiv; van Kalken, Coenraad K.; Witjes, J. Alfred

Book ID: 123389271
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 80 KB
Volume: 176
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2006.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II marker lesion study with intrav

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response: van der Heijden AG, Moonen PM, Cornel EB, Vergunst H, de Reijke TM, van Boven E, Barten EJ, Puri R, van Kalken CK, Witjes JA, University Medical Centre Nijmegen, Nijmegen, The Netherlands

✍ H. Barton Grossman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

PHASE II MARKER LESION STUDY WITH INTRAV

PHASE II MARKER LESION STUDY WITH INTRAVESICAL INSTILLATION OF EOQUIN TM IN SUPERFICIAL BLADDER CANCER, TOXICITY AND MARKER RESPONSE - THE FINAL RESULTS

✍ A.G. Van der Heijden; P.M.J. Moonen; E.B. Cornel; H. Vergunst; T.M. De Reijke; E 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PD-11.11: Phase II marker lesion study w

PD-11.11: Phase II marker lesion study with intravesical instillation of Eoquin™ in superficial bladder cancer: toxicity, marker response and follow up

✍ A.G. van der Heijden; K. Hendricksen; E.B. Cornel; H. Vergunst; T.M. de Reijke; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

873Phase 2 marker lesion study with intr

873Phase 2 marker lesion study with intravesical instillation of eoquin™ in superficial bladder cancer — Preliminary results of the marker response

✍ A. Van der Heijden; P. Moonen; T. De Reijke; E. Van Boven; H. Vergunst; E. Barte 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Phase I/II Pilot Study of Intravesical A

Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer

✍ Puri, Rajiv; Palit, Victor; Loadman, Paul M.; Flannigan, Michael; Shah, Tariq; C 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 318 KB

Two-year follow-up of the phase II marke

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

✍ Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; The 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 286 KB